Line Skute Bråten (Line S Bråten)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Ejection Fraction

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Clinical and translational science

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Magnus Ingelman-Sundberg, Marin M Jukić, Line Skute Bråten, Marianne Kristiansen Kringen, Espen Molden
What is the Current Clinical Impact of the CYP2CTG Haplotype? Clinical pharmacology and therapeutics (2023)
Line Skute Bråten, Magnus Ingelman-Sundberg, Marin M Jukic, Espen Molden, Marianne Kristiansen Kringen
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population. Clinical and translational science 15 (9) (2022)
Line Skute Bråten, Tore Haslemo, Marin M Jukic, Magnus Ingelman-Sundberg, Espen Molden, Marianne K Kringen
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (3) (2019)